On Friday, Accolade Inc (NASDAQ: ACCD) opened at On Friday, remained unchanged from the last session, before settling in for the closing price of $6.88. Price fluctuations for ACCD have ranged from $3.08 to $13.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 36.31% over the past five years. Company’s average yearly earnings per share was noted -3.21% at the time writing. With a float of $70.00 million, this company’s outstanding shares have now reached $81.19 million.
Let’s look at the performance matrix of the company that is accounted for 2400 employees. In terms of profitability, gross margin is 42.92%, operating margin of -41.29%, and the pretax margin is -39.96%.
Accolade Inc (ACCD) Insider Updates
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Accolade Inc is 14.30%, while institutional ownership is 77.12%. The most recent insider transaction that took place on Feb 04 ’25, was worth 3,103. In this transaction Chief Financial Officer of this company sold 448 shares at a rate of $6.93, taking the stock ownership to the 301,364 shares. Before that another transaction happened on Feb 04 ’25, when Company’s President sold 557 for $6.93, making the entire transaction worth $3,858. This insider now owns 216,100 shares in total.
Accolade Inc (ACCD) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.82% during the next five years compared to -2.85% drop over the previous five years of trading.
Accolade Inc (NASDAQ: ACCD) Trading Performance Indicators
Check out the current performance indicators for Accolade Inc (ACCD). In the past quarter, the stock posted a quick ratio of 2.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Accolade Inc (ACCD)
Accolade Inc (NASDAQ: ACCD) saw its 5-day average volume 1.75 million, a negative change from its year-to-date volume of 3.4 million. As of the previous 9 days, the stock’s Stochastic %D was 33.33%. Additionally, its Average True Range was 0.13.
During the past 100 days, Accolade Inc’s (ACCD) raw stochastic average was set at 98.19%, which indicates a significant increase from 26.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.21% in the past 14 days, which was lower than the 120.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.94, while its 200-day Moving Average is $4.84. Nevertheless, the first resistance level for the watch stands at $6.90 in the near term. At $6.93, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.94. If the price goes on to break the first support level at $6.86, it is likely to go to the next support level at $6.85. Assuming the price breaks the second support level, the third support level stands at $6.82.
Accolade Inc (NASDAQ: ACCD) Key Stats
There are currently 81,586K shares outstanding in the company with a market cap of 561.95 million. Presently, the company’s annual sales total 414,290 K according to its annual income of -99,810 K. Last quarter, the company’s sales amounted to 105,060 K and its income totaled -121,260 K.
